Cook Research Incorporated
The purpose of collecting this data is to continue to learn more about the EchoTip AcuCore and the device's ability to produce the desired favorable effect and if there are any undesired outcomes that may be related to the EchoTip AcuCore.
Adenocarcinoma
Neuroendocrine Tumors
Hepatocellular Carcinoma
Cholangiocarcinoma
Malignant Lymphoma
Metastasis
Chronic Pancreatitis
Autoimmune Pancreatitis
EchoTip AcuCore
Study Type : | Observational |
Estimated Enrollment : | 183 participants |
Official Title : | EchoTip AcuCore Post-Market Clinical Study |
Actual Study Start Date : | June 1, 2024 |
Estimated Primary Completion Date : | June 1, 2025 |
Estimated Study Completion Date : | June 1, 2025 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.